CHANGES IN BIOMARKER STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

被引：0
|
作者：
Matsumoto, A. [1 ]
Takahashi, M. [1 ]
Hayashida, T. [1 ]
Hirose, S. [2 ]
Jinno, H. [1 ]
Kitagawa, Y. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan
[2] Keio Univ, Sch Med, Tokyo, Japan
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [31] MANAGEMENT OF INFLAMMATORY BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY
    Abrous-Anane, Soumya
    Savignoni, Alexia
    Daveau, Caroline
    Pierga, Jean-Yves
    Gautier, Chantal
    Reyal, Fabien
    Dendale, Remi
    Campana, Francois
    Kirova, Youlia M.
    Fourquet, Alain
    Bollet, Marc A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1055 - 1063
  • [32] Management of the axilla after neoadjuvant chemotherapy for breast cancer
    Peeters, M. T. F. D. Vrancken
    BRITISH JOURNAL OF SURGERY, 2019, 106 (12) : 1571 - 1573
  • [33] Indication of radiotherapy after neoadjuvant chemotherapy in breast cancer
    Selz, J.
    Le Scodan, R.
    Menard, J.
    Hennequin, C.
    Quero, L.
    CANCER RADIOTHERAPIE, 2014, 18 (03): : 229 - 234
  • [34] Residual Disease After Neoadjuvant Chemotherapy for Breast Cancer
    Morris, Gloria J.
    Robinson, Patricia A.
    Lo, Shelly
    Samuel, Thomas A.
    Sheikh, Asad A.
    Jordan, W. Edward, III
    Thomas, Lisa C.
    Kiel, Krystyna
    Peters, Christopher A.
    SEMINARS IN ONCOLOGY, 2010, 37 (01) : 1 - 10
  • [35] Locoregional Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
    Carr, M. J.
    Sun, J.
    Kiluk, J. V.
    Sun, W.
    Zhou, J.
    Kim, Y.
    Laronga, C.
    Lee, M. C.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S147 - S148
  • [36] Neoadjuvant chemotherapy (NCT) in 710 patients for operable breast cancer:: changes in hormonal receptors (HR) status after treatment.
    Tacca, O. O. T.
    Penault-Llorca, F. F. P. L.
    Mouret-Reynier, M-AMAMR
    Abrial, C. C. A.
    Raoelfils, I. I. R.
    Durando, X. X. D.
    Achard, J-LJLA
    Gimbergues, P. P. C.
    Cure, H. H. C.
    Chollet, P. P. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S165 - S165
  • [37] Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
    Long, Mengping
    You, Chong
    Song, Qianqian
    Hu, Lina X. J.
    Guo, Zhaorong
    Yao, Qian
    Hou, Wei
    Sun, Wei
    Liang, Baosheng
    Zhou, Xiao-Hua
    Liu, Yiqiang
    Hu, Taobo
    LIFE-BASEL, 2023, 13 (01):
  • [38] Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT)
    Sohn, Joohyuk
    Liu, Shuyling
    Chen, Huiqin
    Meng, Xiaolong
    Kim-Anh Do
    Mills, Gordon B.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72
  • [39] Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration
    Zhou, Xingchen
    Zhang, Junyong
    Yun, Haiqin
    Shi, Ranran
    Wang, Yan
    Wang, Wei
    Lagercrantz, Svetlana Bajalica
    Mu, Kun
    ONCOTARGET, 2015, 6 (34) : 36894 - 36902
  • [40] Alteration of tumor marker status after neoadjuvant chemotherapy in locally advanced breast cancer.
    Lee, J. W.
    Ko, E.
    Cho, J.
    Hwang, K-T
    Kim, S. W.
    Park, I-A
    Han, W.
    Noh, D-Y
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S153 - S153
12345